Grassley, Wyden Invite Drugmakers to Testify at Feb. 29 Pricing Hearing

Drug Industry Daily
Leaders of the Senate Finance Committee invited seven leading drug companies to testify in an upcoming hearing on drug pricing — and hinted that they will take a more aggressive approach if the drugmakers decline the invitation.

To View This Article:


Subscribe To Drug Industry Daily